Literature DB >> 7648440

Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma.

K N Dileepan1, J C Page, Y Li, D J Stechschulte.   

Abstract

Interferon-gamma (IFN-gamma) is known to prime macrophages for tumor cell lysis and nitric oxide (NO) production as measured by enhanced sensitivity to lipopolysaccharide (LPS). In the present study, the ability of IFN-gamma to directly activate peritoneal macrophages from C57BL/6 and Balb/c mice for tumor cytotoxicity and NO production was evaluated. Macrophage-mediated tumor cell killing was measured by an 18 h 51Cr release assay using P815 mastocytoma cells as targets. Concurrent NO production was measured as nitrite in the supernatants of macrophage cultures. Incubation of macrophages with IFN-gamma resulted in activation of macrophages for tumor cell lysis. IFN-gamma alone also activated macrophages for NO production under identical conditions. Addition of LPS along with IFN-gamma resulted in synergism in the activation of macrophages for both cytolysis and NO production. LPS contamination of the IFN-gamma preparation was absent as evidenced by the following criteria: (1) the IFN-gamma preparation as well as the reagents used were shown to be free of LPS contamination based on LAL endotoxin tests (sensitivity 25 pg/ml), (2) the ability of IFN-gamma to activated macrophages was not abrogated by prior treatment of the cytokine with polymyxin B, whereas the effect of LPS was inhibited (70-100%) under similar conditions, (3) pretreatment of the IFN-gamma preparation with a specific endotoxin neutralizing protein did not abrogate the ability of IFN-gamma to induce macrophage activation, and (4) heat treatment of solutions containing IFN-gamma alone or IFN-gamma+LPS abolished only the effect of IFN-gamma, not that of LPS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648440     DOI: 10.1089/jir.1995.15.387

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  12 in total

1.  Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1.

Authors:  T K Held; X Weihua; L Yuan; D V Kalvakolanu; A S Cross
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Human conjunctival epithelial cells lack lipopolysaccharide responsiveness due to deficient expression of MD2 but respond after interferon-gamma priming or soluble MD2 supplementation.

Authors:  Jaya Talreja; Kavitha Dileepan; Sanjeev Puri; Mohammad H Kabir; David M Segal; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

3.  Effect of Tityus serrulatus venom on cytokine production and the activity of murine macrophages.

Authors:  Vera L Petricevich
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

4.  Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.

Authors:  A H Klimp; J Regts; G L Scherphof; E G de Vries; T Daemen
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

Review 5.  Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

6.  Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.

Authors:  Elisabeth Müller; Panagiotis F Christopoulos; Sanjib Halder; Anna Lunde; Kahsai Beraki; Martin Speth; Inger Øynebråten; Alexandre Corthay
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

7.  4-Acetylantroquinonol B inhibits lipopolysaccharide-induced cytokine release and alleviates sepsis through of MAPK and NFκB suppression.

Authors:  Chien-Hsin Chang; Chun-Chieh Hsu; An-Sheng Lee; Shih-Wei Wang; Kung-Tin Lin; Wei-Luen Chang; Hui-Chin Peng; Wen-Chiung Huang; Ching-Hu Chung
Journal:  BMC Complement Altern Med       Date:  2018-03-23       Impact factor: 3.659

8.  Peripheral helper lymphocytes produce interleukin 12 in cancer patients.

Authors:  Márcia A Michelin; Douglas R Abdalla; André A R Aleixo; Eddie F C Murta
Journal:  Clin Med Insights Oncol       Date:  2013-03-06

9.  Reactive oxygen species and nitric oxide in cutaneous leishmaniasis.

Authors:  Maria Fátima Horta; Bárbara Pinheiro Mendes; Eric Henrique Roma; Fátima Soares Motta Noronha; Juan Pereira Macêdo; Luciana Souza Oliveira; Myrian Morato Duarte; Leda Quercia Vieira
Journal:  J Parasitol Res       Date:  2012-04-12

10.  A defective TLR4 signaling for IFN-β expression is responsible for the innately lower ability of BALB/c macrophages to produce NO in response to LPS as compared to C57BL/6.

Authors:  Luciana S Oliveira; Nina M G P de Queiroz; Laura V S Veloso; Thaís G Moreira; Fernanda S Oliveira; Matheus B H Carneiro; Ana M Faria; Leda Q Vieira; Sérgio C Oliveira; Maria F Horta
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.